These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation. Taheri M; Pourmand G; Mehrsai AR; Mansoori D Transplant Proc; 2003 Nov; 35(7):2752-3. PubMed ID: 14612105 [No Abstract] [Full Text] [Related]
8. Mycophenolate mofetil severely depresses antibody response to CMV infection in early posttransplant period. Zmonarski SC; Boratynska M; Madziarska K; Klinger M; Kusztel M; Patrzalek D; Szyber P Transplant Proc; 2003 Sep; 35(6):2205-6. PubMed ID: 14529889 [TBL] [Abstract][Full Text] [Related]
9. Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection. Miladipour AH; Ghods AJ; Nejadgashti H Transplant Proc; 2002 Sep; 34(6):2089-90. PubMed ID: 12270325 [No Abstract] [Full Text] [Related]
10. [Factors influencing prevalence and clinical course of cytomegalovirus (CMV) infection in kidney transplant patients]. Szymczakiewicz-Multanowska AM; Kuźniewski M; Zawilińska B; Zgórniak-Nowosielska I; Uracz D; Ignacak E; Betkowska-Prokop A; Sułowicz W Przegl Lek; 2001; 58(7-8):772-7. PubMed ID: 11769385 [TBL] [Abstract][Full Text] [Related]
11. Effects of mycophenolate mofetil on hematocrit after renal transplantation. Chenhsu RY; Wu YM; Min DI; Zimmerman MB Ann Pharmacother; 2002 Sep; 36(9):1479-80. PubMed ID: 12196073 [No Abstract] [Full Text] [Related]
12. Side effects of mycophenolate mofetil versus azathioprine in iranian renal transplant recipients (single-center experience). Hakemi M; Shahebrahimi K; Ganji MR; Najafi I; Broumand B Transplant Proc; 2002 Sep; 34(6):2091-2. PubMed ID: 12270326 [No Abstract] [Full Text] [Related]
13. [Initial experience with mycophenolate mofetil (RS 61443) after kidney transplantation]. Friedrich J; Erhard J Zentralbl Chir; 1994; 119(1):48-9. PubMed ID: 8147160 [No Abstract] [Full Text] [Related]
14. Mycophenolate mofetil in renal transplantation: five years experience. Tuncer M; Gürkan A; Erdoğan O; Demirbaş A; Süleymanlar G; Ersoy FF; Akaydin M; Yakupoğlu G Transplant Proc; 2002 Sep; 34(6):2087-8. PubMed ID: 12270324 [No Abstract] [Full Text] [Related]
15. Upper gastrointestinal bleeding during the first month after renal transplantation in the mycophenolate mofetil era. Ardalan MR; Etemadi J; Somi MH; Ghafari A; Ghojazadeh M Transplant Proc; 2009 Sep; 41(7):2845-7. PubMed ID: 19765453 [TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus risk factors in renal transplantation with modern immunosuppression. Bataille S; Moal V; Gaudart J; Indreies M; Purgus R; Dussol B; Zandotti C; Berland Y; Vacher-Coponat H Transpl Infect Dis; 2010 Dec; 12(6):480-8. PubMed ID: 20629971 [TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil for maintenance therapy in kidney transplantation. Gonwa TA Clin Transplant; 1996 Feb; 10(1 Pt 2):128-30. PubMed ID: 8680049 [TBL] [Abstract][Full Text] [Related]
18. Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients. Fritsche L; Sperschneider H; Budde K; Giessing M; Morgera S; Schröder K; Stein G; Neumayer HH Transplant Proc; 1998 Jun; 30(4):1190-1. PubMed ID: 9636481 [No Abstract] [Full Text] [Related]
19. Effects of mycophenolate mofetil on the gastrointestinal system and kidney graft function: early experience at one center. Karakayali H; Yagmurdur MC; Emiroglu R; Moray G; Colak T Transplant Proc; 2002 Sep; 34(6):2093-5. PubMed ID: 12270327 [No Abstract] [Full Text] [Related]
20. The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation. ter Meulen CG; Wetzels JF; Hilbrands LB Nephrol Dial Transplant; 2000 May; 15(5):711-4. PubMed ID: 10809816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]